Literature DB >> 18422748

Opposing effects of interferon-alpha and interferon-gamma on the expression of major histocompatibility complex class I chain-related A in tumors.

Cai Zhang1, Jiafeng Niu, Jianhua Zhang, Yiping Wang, Zhixia Zhou, Jian Zhang, Zhigang Tian.   

Abstract

Natural killer cells are an important component of innate resistance to viruses, bacteria, certain parasites, and tumors. The activating receptor natural killer group 2D (NKG2D) plays a critical role in the elimination of tumor cells by cytotoxic effector cells. It has been shown that the strength of an antitumor immune response might be critically dependent on NKG2D ligard surface levels. Thus, it is essential to regulate the expression of NKG2D ligands in order to ensure effective tumor immunosurveillance and the elimination of pathogen-infected cells. In the present study, we found that interferon (IFN)-alpha and IFNgamma exert opposing effects on major histocompatibility complex class I-related chain A (MICA) expression in human tumor cells. IFNalpha promotes expression of the NKG2D ligand MICA in tumor cells and therefore enhances their sensitivity to natural killer lysis. In contrast, IFNgamma exerts the opposite effect. IFNalpha promotes MICA expression at the level of transcription by augmenting MICA promoter activity. IFNgamma modulates MICA expression not only at the transcriptional level, but also at the post-translational level by promoting proteolytic cleavage by matrix metalloproteinases. Further study is needed to clarify the precise regulatory mechanisms. The pathways involved in NKG2D ligand induction might represent a promising target for improving immune responses to cancer or infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18422748     DOI: 10.1111/j.1349-7006.2008.00791.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  16 in total

Review 1.  Combination strategies to enhance antitumor ADCC.

Authors:  Holbrook E Kohrt; Roch Houot; Aurélien Marabelle; Hearn Jay Cho; Keren Osman; Matthew Goldstein; Ronald Levy; Joshua Brody
Journal:  Immunotherapy       Date:  2012-05       Impact factor: 4.196

2.  In vivo major histocompatibility complex class I (MHCI) expression on MHCIlow tumor cells is regulated by gammadelta T and NK cells during the early steps of tumor growth.

Authors:  Joëlle Riond; Stéphane Rodriguez; Marie-Laure Nicolau; Talal al Saati; Jean Edouard Gairin
Journal:  Cancer Immun       Date:  2009-11-02

3.  Role of CC chemokine receptor 4 in natural killer cell activation during acute cigarette smoke exposure.

Authors:  Valerie R Stolberg; Brian Martin; Peter Mancuso; Michal A Olszewski; Christine M Freeman; Jeffrey L Curtis; Stephen W Chensue
Journal:  Am J Pathol       Date:  2013-12-09       Impact factor: 4.307

Review 4.  Regulation of ligands for the NKG2D activating receptor.

Authors:  David H Raulet; Stephan Gasser; Benjamin G Gowen; Weiwen Deng; Heiyoun Jung
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

Review 5.  Circulating Tumor Cells: Does Ion Transport Contribute to Intravascular Survival, Adhesion, Extravasation, and Metastatic Organotropism?

Authors:  Christian Stock
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

6.  Down-regulation of UL16-binding protein 3 mediated by interferon-gamma impairs immune killing in nasopharyngeal carcinoma.

Authors:  Lingling Guo; Yu Chen; Jing Wang; Chuanben Chen
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

7.  Cutting edge: down-regulation of MHC class I-related chain A on tumor cells by IFN-gamma-induced microRNA.

Authors:  Deepak Yadav; Jennifer Ngolab; Rod Seung-Hwan Lim; Siddharth Krishnamurthy; Jack D Bui
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

Review 8.  NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma.

Authors:  Cheng Sun; Haoyu Sun; Cai Zhang; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2014-10-13       Impact factor: 11.530

9.  Intragenic transcriptional interference regulates the human immune ligand MICA.

Authors:  Da Lin; Thomas K Hiron; Christopher A O'Callaghan
Journal:  EMBO J       Date:  2018-04-11       Impact factor: 11.598

10.  Human NKG2D-ligands: cell biology strategies to ensure immune recognition.

Authors:  Lola Fernández-Messina; Hugh T Reyburn; Mar Valés-Gómez
Journal:  Front Immunol       Date:  2012-09-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.